GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioInvent International BINV.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

2.95

+18.47%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

BioInvent International annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2020
RevenueSEK 226.5mSEK 44.7mSEK 71.5mSEK 326.1mSEK 147.4m
Operating income−SEK 351.4m−SEK 471.1m−SEK 369.9m−SEK 50.9m−SEK 76.0m
Net income−SEK 332.9m−SEK 429.4m−SEK 330.3m−SEK 34.1m−SEK 76.7m
Free cash flow−SEK 255.0m−SEK 390.5m−SEK 355.0m−SEK 53.6m−SEK 69.3m
Total assetsSEK 671.2mSEK 989.2mSEK 1.40bnSEK 1.71bnSEK 802.6m
Shareholders' equitySEK 557.6mSEK 885.8mSEK 1.31bnSEK 1.61bnSEK 743.5m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.